Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Kenneth Kobak |
Documentos disponibles escritos por este autor (4)
Refinar búsquedaDevelopment of three web-based computerized versions of the kiddie schedule for affective disorders and schizophrenia child psychiatric diagnostic interview / Lisa Townsend en Journal of the American Academy of Child & Adolescent Psychiatry, Año 2020 - Vol. 59 - No.2 (Febrero)
Título : Development of three web-based computerized versions of the kiddie schedule for affective disorders and schizophrenia child psychiatric diagnostic interview : preliminary validity data Tipo de documento: texto impreso Autores: Lisa Townsend, Autor ; Kenneth Kobak, Autor ; Catherine Kearney, Autor Fecha de publicación: 2020 Artículo en la página: pp. 309–325 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Diagnósticos psiquiátricos en niños y adolescentes, Evaluación computarizada, K-SADS Resumen: To present initial validity data on three web-based computerized versions of the Kiddie Schedule for Affective Disorders and Schizophrenia (KSADS-COMP). Link: ./index.php?lvl=notice_display&id=22710
in Journal of the American Academy of Child & Adolescent Psychiatry > Año 2020 - Vol. 59 - No.2 (Febrero) . - pp. 309–325[artículo] Development of three web-based computerized versions of the kiddie schedule for affective disorders and schizophrenia child psychiatric diagnostic interview : preliminary validity data [texto impreso] / Lisa Townsend, Autor ; Kenneth Kobak, Autor ; Catherine Kearney, Autor . - 2020 . - pp. 309–325.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of the American Academy of Child & Adolescent Psychiatry > Año 2020 - Vol. 59 - No.2 (Febrero) . - pp. 309–325
Palabras clave: Diagnósticos psiquiátricos en niños y adolescentes, Evaluación computarizada, K-SADS Resumen: To present initial validity data on three web-based computerized versions of the Kiddie Schedule for Affective Disorders and Schizophrenia (KSADS-COMP). Link: ./index.php?lvl=notice_display&id=22710
Título : Fluoxetine in social phobia: a double-blind, placebo-controlled pilot study Tipo de documento: texto impreso Autores: Kenneth Kobak, Autor ; John H. Greist, Autor ; James W. Jefferson, Autor Fecha de publicación: 2023 Artículo en la página: pp. 257-262 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Fluoxetina, Trastornos fóbicos, Inhibidores selectivos de la recaptación de serotonina. Resumen: The objective of the study was to examine the efficacy of fluoxetine in social phobia. Sixty subjects were randomly assigned to 14 weeks of double-blind therapy with either fluoxetine or placebo. Dose was fixed at 20 mg for fluoxetine during the first 8 weeks of double-blind treatment; during the final 6 weeks, the dose could be increased every two weeks by 20 mg to a maximum of 60 mg/day. An intentto-treat analysis was used. Link: ./index.php?lvl=notice_display&id=31064
in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 3 (Junio) . - pp. 257-262[artículo] Fluoxetine in social phobia: a double-blind, placebo-controlled pilot study [texto impreso] / Kenneth Kobak, Autor ; John H. Greist, Autor ; James W. Jefferson, Autor . - 2023 . - pp. 257-262.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 3 (Junio) . - pp. 257-262
Palabras clave: Fluoxetina, Trastornos fóbicos, Inhibidores selectivos de la recaptación de serotonina. Resumen: The objective of the study was to examine the efficacy of fluoxetine in social phobia. Sixty subjects were randomly assigned to 14 weeks of double-blind therapy with either fluoxetine or placebo. Dose was fixed at 20 mg for fluoxetine during the first 8 weeks of double-blind treatment; during the final 6 weeks, the dose could be increased every two weeks by 20 mg to a maximum of 60 mg/day. An intentto-treat analysis was used. Link: ./index.php?lvl=notice_display&id=31064
Título : A new approach to rater training and certification in a multicenter clinical trial Tipo de documento: texto impreso Autores: Kenneth Kobak, Autor ; Joshua D. Lipsitz, Autor ; Janet B. W. Williams, Autor Fecha de publicación: 2023 Artículo en la página: pp. 407-412 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos, Competencia clínica, Ensayos clínicos como tema, Trastorno depresivo, Personal de investigación - educación Resumen: Recent evidence demonstrates that the quality of raters' applied clinical skills is directly related to study outcome. As such, the training and evaluation of raters' clinical skill in administering symptom-rating scales is essential before being certified to rate patients in clinical trials. Link: ./index.php?lvl=notice_display&id=30884
in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 5 (Octubre) . - pp. 407-412[artículo] A new approach to rater training and certification in a multicenter clinical trial [texto impreso] / Kenneth Kobak, Autor ; Joshua D. Lipsitz, Autor ; Janet B. W. Williams, Autor . - 2023 . - pp. 407-412.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 5 (Octubre) . - pp. 407-412
Palabras clave: Antidepresivos, Competencia clínica, Ensayos clínicos como tema, Trastorno depresivo, Personal de investigación - educación Resumen: Recent evidence demonstrates that the quality of raters' applied clinical skills is directly related to study outcome. As such, the training and evaluation of raters' clinical skill in administering symptom-rating scales is essential before being certified to rate patients in clinical trials. Link: ./index.php?lvl=notice_display&id=30884
Título : St. John's wort versus placebo in social phobia : Results from a placebo-controlled pilot study Tipo de documento: texto impreso Autores: Kenneth Kobak, Autor ; Leslie v.H Taylor, Autor ; Gemma Warner, Autor Fecha de publicación: 2023 Artículo en la página: pp. 51-58 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Hipérico, Trastornos fóbicos, Fitoterapia - efectos adversos Resumen: Recognition of social anxiety disorder (social phobia) as a common and disabling condition has led to new advances in its pharmacotherapy. Limitations with selective seroton reuptake inhibitors (side effects) and behavior therapy (scarcity of trained therapists), coupled with the tendency for patients with the disorder to self-medicate with alternative treatments, have led to the interest in Saint John's wort (SJW) (Hypericum perforatum) for this disorder. Link: ./index.php?lvl=notice_display&id=30925
in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 1 (Febrero) . - pp. 51-58[artículo] St. John's wort versus placebo in social phobia : Results from a placebo-controlled pilot study [texto impreso] / Kenneth Kobak, Autor ; Leslie v.H Taylor, Autor ; Gemma Warner, Autor . - 2023 . - pp. 51-58.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 1 (Febrero) . - pp. 51-58
Palabras clave: Hipérico, Trastornos fóbicos, Fitoterapia - efectos adversos Resumen: Recognition of social anxiety disorder (social phobia) as a common and disabling condition has led to new advances in its pharmacotherapy. Limitations with selective seroton reuptake inhibitors (side effects) and behavior therapy (scarcity of trained therapists), coupled with the tendency for patients with the disorder to self-medicate with alternative treatments, have led to the interest in Saint John's wort (SJW) (Hypericum perforatum) for this disorder. Link: ./index.php?lvl=notice_display&id=30925
